Nemaura Medical evolved from a Micro-system based drug delivery platform in 2011. Since then we have developed the platform to allow the monitoring of multiple chemicals in the blood, without using needles.
Replacing traditional invasive methods of diagnosis and healthcare observation procedures, our BEAT™ technology will allow for remote continuous monitoring of chronic diseases and health conditions.
One of the great advantages of our product apart from the fact that you no longer need to draw blood samples or insert a needle or sensor inside the skin, is that a person can wear the device on whatever day they choose and for however long they choose. This is a unique feature of our device and a world first, opening up vast potential for changing the way we manage chronic disease conditions.
Nemaura have combined their in-house diagnostic platform technology with digital healthcare platforms through partnerships and by bringing in artificial intelligence development capabilities in-house. Our technology offering will grow to encompass a combination of AI, devices, and digital platforms, with which Nemaura is positioning itself to become a significant player in the digital healthcare revolution.